Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.

Loi S, Symmans WF, Bartlett JM, Fumagalli D, Van't Veer L, Forbes JF, Bedard P, Denkert C, Zujewski J, Viale G, Pusztai L, Esserman LJ, Leyland-Jones BR.

Lancet Oncol. 2011 Nov;12(12):1162-8. doi: 10.1016/S1470-2045(11)70117-6.

PMID:
21684810
2.

Recommendations for collection and handling of specimens from group breast cancer clinical trials.

Leyland-Jones BR, Ambrosone CB, Bartlett J, Ellis MJ, Enos RA, Raji A, Pins MR, Zujewski JA, Hewitt SM, Forbes JF, Abramovitz M, Braga S, Cardoso F, Harbeck N, Denkert C, Jewell SD; Breast International Group; Cooperative Groups of the Breast Cancer Intergroup of North America (TBCI); American College of Surgeons Oncology Group; Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; National Cancer Institute of Canada Clinical Trials Group; Southwest Oncology Group; National Surgical Adjuvant Breast and Bowel Project; Radiation Oncology Group; Gynecologic Oncology Group; Children's Oncology Group.

J Clin Oncol. 2008 Dec 1;26(34):5638-44. doi: 10.1200/JCO.2007.15.1712. Epub 2008 Oct 27.

3.
4.

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.

Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration.

Mod Pathol. 2015 Sep;28(9):1185-201. doi: 10.1038/modpathol.2015.74. Epub 2015 Jul 24.

5.

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M; BIG-NABCG collaboration.

Lancet Oncol. 2012 Jun;13(6):e240-8. doi: 10.1016/S1470-2045(11)70378-3.

PMID:
22652232
6.

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Viale G, Cameron D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration.

Ann Oncol. 2015 Jul;26(7):1280-91. doi: 10.1093/annonc/mdv161. Epub 2015 May 27. Review.

7.

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.

Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS.

Clin Chem. 2007 Jul;53(7):1273-9. Epub 2007 May 24.

8.

Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer.

Jarzab M, Rózanowski P, Kowalska M, Zebracka J, Rudnicka L, Stobiecka E, Jarzab B, Stachura J, Pawlega J.

Pol J Pathol. 2008;59(2):85-91.

PMID:
18669173
9.

Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer.

Paik S, Kim CY, Song YK, Kim WS.

Nat Clin Pract Oncol. 2005 May;2(5):246-54. Review.

PMID:
16264960
10.

Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.

Belloni B, Lambertini C, Nuciforo P, Phillips J, Bruening E, Wong S, Dummer R.

J Clin Pathol. 2013 Feb;66(2):124-35. doi: 10.1136/jclinpath-2012-200983. Epub 2012 Nov 3.

11.

Standardized processing of native tissue in breast pathology.

Dämmrich ME, Kreipe HH.

Recent Results Cancer Res. 2015;199:45-53. doi: 10.1007/978-3-319-13957-9_5.

PMID:
25636428
12.

Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling.

Hicks DG, Kushner L, McCarthy K.

J Natl Cancer Inst Monogr. 2011;2011(42):43-5. doi: 10.1093/jncimonographs/lgr003.

PMID:
21672896
13.

[Histological and cytopathological cancer specimens: good practice in operating room].

Benoit L, Favoulet P, Collin F, Arnould L, Fraisse J, Cuisenier J.

Ann Chir. 2003 Nov;128(9):637-41. Review. French.

PMID:
14659622
14.

Comparison of formalin, ethanol, and Histochoice fixation on the PCR amplification from paraffin-embedded breast cancer tissue.

Giannella C, Zito FA, Colonna F, Paradiso A, Marzullo F, Alaibac M, Schittulli F.

Eur J Clin Chem Clin Biochem. 1997 Aug;35(8):633-5.

PMID:
9298355
15.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.

16.

Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.

Turashvili G, Yang W, McKinney S, Kalloger S, Gale N, Ng Y, Chow K, Bell L, Lorette J, Carrier M, Luk M, Aparicio S, Huntsman D, Yip S.

Exp Mol Pathol. 2012 Feb;92(1):33-43. doi: 10.1016/j.yexmp.2011.09.013. Epub 2011 Sep 21.

PMID:
21963600
17.

The pre-analytical phase in surgical pathology.

Bussolati G, Annaratone L, Maletta F.

Recent Results Cancer Res. 2015;199:1-13. doi: 10.1007/978-3-319-13957-9_1.

PMID:
25636424
18.

Biobanking in genomic medicine.

Zhou JH, Sahin AA, Myers JN.

Arch Pathol Lab Med. 2015 Jun;139(6):812-8. doi: 10.5858/arpa.2014-0261-RA. Review.

19.

[Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].

Solá M, Fraile M.

Rev Esp Med Nucl. 2010 Nov-Dec;29(6):316-8. doi: 10.1016/j.remn.2010.10.001. Review. Spanish. No abstract available.

20.

Is breast specimen shrinkage really a problem in breast-conserving surgery?

Krekel NM, van Slooten HJ, Barbé E, de Lange de Klerk ES, Meijer S, van den Tol MP.

J Clin Pathol. 2012 Mar;65(3):224-7. doi: 10.1136/jclinpath-2011-200392. Epub 2011 Nov 2.

PMID:
22049220

Supplemental Content

Support Center